Last checked · How I check · Follow this CEO
Max Noble
Coloplast
Kristian Villumsen promised 7–9% growth a year and a margin above 30%. Delivered: 7% growth, 28% margin.
Sales would grow 7–9% a year and the margin would be above 30%.
Kristian Villumsen, CEO, 2018–2025, on 30 September 2020.
He got7% growth and a 28% margin in the final year.
Stamp: Partly kept.
Why, says the companyProduct recalls, inflation and acquisitions weighed on profits.
How badNear miss. Growth reached only the bottom of the range and the margin goal was missed. The CEO’s Integrity Score went from 0.0 to −2.5.
In the company’s own wordsColoplast named product recalls in Urology and Advanced Wound Care, inflation and higher interest rates that raised input costs, weaker China and the effects of acquisitions. Villumsen stepped down on 5 May 2025; interim CEO Lars Rasmussen reported the final year.
The sources- Coloplast full-year 2019/20 press release, 3 Nov 2020
- Coloplast full-year 2024/25 results announcement, 4 Nov 2025
- Coloplast 2024/25 'kort fortalt' (chair/CEO letter)
Last checked 30 October 2026: the sources were opened again and the promise and the stamp still stand. How I check.
Get an email the morning Kristian Villumsen’s card turns.
One email when the stamp changes or a new promise is checked. Nothing else.